StockWatch
·
Biotechnology: Pharmaceutical Preparations
Loan & DebtJul 1, 2026, 04:27 PM

Viatris Secures ¥40B Amended Term Loan Credit Facility

AI Summary

Viatris Inc. has entered into an amended and restated term loan credit agreement for ¥40,000,000,000 (approximately $250 million USD) with Mizuho Bank, Ltd. as the administrative agent. The proceeds from this new facility will be used to repay outstanding obligations under a previous ¥40 billion unsecured term loan facility and for general corporate purposes. The loan bears an initial interest rate of TIBO Rate plus 1.10% per annum and matures three years from the closing date of July 1, 2026. The agreement includes customary covenants, such as a financial covenant requiring a leverage ratio no greater than 3.75 to 1.00.

Key Highlights

  • Viatris entered into an amended and restated term loan credit agreement.
  • The new facility is for ¥40,000,000,000 (approximately $250 million USD).
  • Proceeds will repay outstanding obligations under a prior ¥40B facility.
  • Funds will also be used for general lawful corporate purposes.
  • Mizuho Bank, Ltd. is the administrative agent for the facility.
  • Initial interest rate is TIBO Rate plus 1.10% per annum.
  • The loan matures three years from the closing date (July 1, 2026).
  • A financial covenant requires a leverage ratio no greater than 3.75 to 1.00.